Pear Therapeutics

Alison Bauerlein

Ms. Bauerlein has served as a member of Pear’s board of directors since December 2021 and is a member of both the Audit Committee and Compensation Committee. She is a cofounder of Inogen, Inc (Nasdaq: INGN) and has served as its chief financial officer since 2009 and executive vice president, Finance since March 2014. Ms. Bauerlein has also served as corporate secretary from 2002 until July 2021 and corporate treasurer since 2002. Ms. Bauerlein previously served as Inogen Inc’s vice president, Finance from 2008 until March 2014. Prior to serving in these positions, she also served as controller with Inogen, Inc from 2008 to 2009 and 2001 to 2004, and the director of Financial Planning and Analysis from 2004 to 2008. Ms. Bauerlein has over 20 years of experience in treasury, finance, accounting, and risk management, as well as strategic and tactical cost analysis and forecasting. Ms. Bauerlein received a BA in economics/mathematics with high honors from the University of California, Santa Barbara. b